Patrick M. Shea

Chief Executive Officer at Intrance Medical Systems, Inc.

Health Technology

Profile

Patrick M.
Shea is currently the Chief Executive Officer & Director at Intrance Medical Systems, Inc. He previously worked as a Director at OSI Pharmaceuticals, Inc.

Patrick M. Shea active positions

Companies	Position	Start
Intrance Medical Systems, Inc. Intrance Medical Systems, Inc. Pharmaceuticals: MajorHealth Technology Intrance Medical Systems, Inc. is a company focused on developing and commercializing clinical products for the treatment of advanced Parkinson's disease. The company is based in Albany, NY. Recently, the company appointed Ashley Prange as Vice President of Business Development to strengthen its focus on strategic partnerships, including out-licensing activities and commercial collaborations. Parkinson's disease is the second most common neurodegenerative disorder, affecting nearly one million people in the United States. The company was founded in 2018 by Ulf Rosén and Roger Bolsöy. The CEO is Patrick M. Shea.	Chief Executive Officer	12/05/2021

All active positions of Patrick M. Shea

Former positions of Patrick M. Shea

Companies	Position	End
OSI PHARMACEUTICALS, INC.	Director/Board Member	-

See the detail of Patrick M. Shea's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Patrick M. Shea's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
OSI Pharmaceuticals, Inc. OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY.	Health Technology
Intrance Medical Systems, Inc. Intrance Medical Systems, Inc. Pharmaceuticals: MajorHealth Technology Intrance Medical Systems, Inc. is a company focused on developing and commercializing clinical products for the treatment of advanced Parkinson's disease. The company is based in Albany, NY. Recently, the company appointed Ashley Prange as Vice President of Business Development to strengthen its focus on strategic partnerships, including out-licensing activities and commercial collaborations. Parkinson's disease is the second most common neurodegenerative disorder, affecting nearly one million people in the United States. The company was founded in 2018 by Ulf Rosén and Roger Bolsöy. The CEO is Patrick M. Shea.	Health Technology